Literature for inhibitor I25.065: cystatin 9 (Homo sapiens)

Summary Alignment Sequences Sequence features Distribution Literature
 
    2017
  1. Holloway,A.J., Yu,J., Arulanandam,B.P., Hoskinson,S.M. and Eaves-Pyles,T.
    Cystatin 9 and C: a novel immunotherapy that protects against multi-drug resistant New Delhi metallo-beta-lactamase-1 producing Klebsiella pneumoniae
    Antimicrob Agents Chemother (2017) 62, e01900-17-e01900-17. PubMed  Europe PubMed DOI
  2. 2013
  3. Eaves-Pyles,T., Patel,J., Arigi,E., Cong,Y., Cao,A., Garg,N., Dhiman,M., Pyles,R.B., Arulanandam,B., Miller,A.L., Popov,V.L., Soong,L., Carlsen,E.D., Coletta,C., Szabo,C. and Almeida,I.C.
    Immunomodulatory and antibacterial effects of cystatin 9 against Francisella tularensis
    Mol Med (2013) 19, 263-275. PubMed  Europe PubMed DOI  PMC  EPMC